Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Amgevita“
Suchtreffer
Begriffe & Kennungen
Amgevita · 4.5 · The combination of AMGEVITA and anakinra is not recommended (see section 4.4 “Concurrent administration of bio
Eintrag öffnenAmgevita · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenAmgevita · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenAmgevita · 4.8 Undesirable effects · 1
Eintrag öffnenAmgevita · 4.8 Undesirable effects · 2
Eintrag öffnenAmgevita · 4.8 · 16 Serious adverse reactions have been reported for adalimumab. TNF-antagonists, such as AMGEVITA affect the i
Eintrag öffnenAmgevita · 4.8 · 17 System organ class Frequency Adverse reaction Neoplasms benign, Common Skin cancer excluding melanoma (incl
Eintrag öffnenAmgevita · 4.8 · 18 System organ class Frequency Adverse reaction Cardiac disorders* Common Tachycardia Uncommon Myocardial inf
Eintrag öffnenAmgevita · 4.8 · 19 System organ class Frequency Adverse reaction Skin and subcutaneous Very common Rash (including exfoliative
Eintrag öffnenAmgevita · 4.8 · 20 Uveitis
Eintrag öffnenAmgevita · 4.8 · 21 (95% confidence interval) of lymphomas was 0.7 (0.2, 2.7) per 1,000 patient-years among adalimumab-treated
Eintrag öffnenAmgevita · 4.8 · 22 In controlled trials of adalimumab (initial doses of 160 mg at week 0 and 80 mg at week 2, followed by 40 m
Eintrag öffnenAmgevita · 4.8 · 70 Serious haematological, neurological and autoimmune reactions have also been reported. These include rare r
Eintrag öffnenAmgevita · 4.8 · 71 System organ class Frequency Adverse reactions Neoplasms benign, Common Skin cancer excluding melanoma (inc
Eintrag öffnenAmgevita · 4.8 · 72 System organ class Frequency Adverse reactions Ear and labyrinth Common Vertigo disorders Uncommon Deafness
Eintrag öffnenAmgevita · 4.8 · 73 System organ class Frequency Adverse reactions Skin and subcutaneous Very common Rash (including exfoliativ
Eintrag öffnenAmgevita · 4.8 · 74 Uveitis
Eintrag öffnenAmgevita · 4.8 · 75 control patients. The rate (95% confidence interval) of lymphomas was 0.7 (0.2, 2.7) per 1 000 patient-year
Eintrag öffnenAmgevita · 4.8 · 76 No ALT elevations ≥ 3 × ULN occurred in the phase 3 trial of adalimumab in paediatric patients with plaque
Eintrag öffnenAmgevita · 4.8 · Across all indications in clinical trials patients with raised ALT were asymptomatic and in most cases elevati
Eintrag öffnen